Document Detail


Liver transplantation and cell therapies for inborn errors of metabolism.
MedLine Citation:
PMID:  23296369     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Liver transplantation is now very successful with >85 % long term survival into adult life. When considering the impact of liver transplantation for metabolic disease two independent factors need to be considered; whether or not the defect causes liver disease and whether or not it is confined to the liver. When considering transplantation many factors need to be considered including the local success of transplantation, the impact of the metabolic disease on the patient and family and the potential for future therapeutic developments. Where transplantation is undertaken for a liver based defect there is a lifelong complete correction of the defect. Where there is a residual extrahepatic defect this will have an impact on the outcome of liver transplantation and the severity of this defect must be considered as part of the transplant assessment process. Access to a multi-disciplinary team with expertise in metabolic disease, liver disease and other relevant organ based specialists is crucial. Most children will receive transplantation from cadaveric donor but living related transplantation from a heterozygote parent is usually safe and effective. Auxiliary liver transplantation has a small but useful role where partial correction of the defect is helpful and there is a future prospect of gene therapy. The first-generation of hepatocyte transplants have shown proof of principle but to date have had a rather modest and temporary metabolic effect. Stem cells may have the potential to produce a more sustained and significant metabolic correction, but must be shown to be effective in controlled trials.
Authors:
Patrick McKiernan
Related Documents :
24346809 - The impact of modern treatment principles may have eliminated lithium-induced renal fai...
20733489 - Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategi...
18442299 - Mechanisms and management of proteinuria in kidney transplant patients.
7141789 - Focal segmental glomerulosclerosis, crescent, and rapidly progressive renal failure.
16598199 - Turbulence of glomerular hemodynamics involved in progressive glomerulosclerosis.
23430889 - Female with fabry disease unknowingly donates affected kidney to sister: a call for pre...
11701399 - Naevus anaemicus with teleangiectatic vessels.
24615159 - Biological roles of olfactory ensheathing cells in facilitating neural regeneration: a ...
23680929 - Racial differences and income disparities are associated with poor outcomes in kidney t...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-8
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  -     ISSN:  1573-2665     ISO Abbreviation:  J. Inherit. Metab. Dis.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Liver Unit, Birmingham Children's Hospital, B4 6NH, Birmingham, UK, pat.mckiernan@bch.nhs.uk.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper class...
Next Document:  Glaucoma Screening Using Relative Afferent Pupillary Defect.